Bruno Garcia Montagnini
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Bruno Garcia Montagnini has a total of 35 co-authors. Here are the top co-authors by number of shared publications:
- Daniela Cristina Ceccatto Gerardin
Department of Physiological Sciences, State University of Londrina, Londrina, Paraná, Brazil
6 shared publications Ana Carolina Inhasz Kiss
Department of Physiology, Botucatu Biosciences Institute, São Paulo State University, 18618-970 Botucatu, São Paulo, Brazil
3 shared publicationsJanete Aparecida Anselmo-Franci
Department of Morphology, Estomatology and Physiology, University of São Paulo, 14040-900 Ribeirão Preto, São Paulo, Brazil
3 shared publicationsSuzana de Fátima Paccola Mesquita
Department of Biology, State University of Londrina, 86051-980 Londrina, Paraná, Brazil
3 shared publications- Estefânia Gastaldello Moreira
Health Sciences Graduate Program, Health Sciences Center, State University of Londrina, Londrina, Brazil
2 shared publications Milene Leivas Vieira
Department of Physiological Sciences, State University of Londrina, 86051-980 Londrina, Paraná, Brazil
2 shared publications
Latest Publications
- 1 December 2018
- Published by Elsevier in Toxicology
- Vol. 410, 152-165
Investigation of the potential effects of triclosan as an endocrine disruptor in female rats: Uterotrophic assay and two-generation study
- 1 December 2018
- Published by Elsevier in Toxicology
- Vol. 410, 152-165
Investigation of the potential effects of triclosan as an endocrine disruptor in female rats: Uterotrophic assay and two-generation study
- 1 August 2018
- Published by Elsevier in Life Sciences
- Vol. 207, 72-79
Intrauterine exposure to metformin: Evaluation of endothelial and perivascular adipose tissue function in abdominal aorta of adult offspring
- 1 August 2018
- Published by Elsevier in Life Sciences
- Vol. 207, 72-79
Intrauterine exposure to metformin: Evaluation of endothelial and perivascular adipose tissue function in abdominal aorta of adult offspring
- 1 January 2018
- Published by Elsevier in Reproductive Toxicology
- Vol. 75, 65-72
Evaluation of reproductive toxicity in rats treated with triclosan
- 1 January 2018
- Published by Elsevier in Reproductive Toxicology
- Vol. 75, 65-72
Evaluation of reproductive toxicity in rats treated with triclosan
- 1 December 2016
- Published by Elsevier in Physiology & Behavior
- Vol. 167, 118-124
Reproductive parameters of female Wistar rats treated with methylphenidate during development
- 1 December 2016
- Published by Elsevier in Physiology & Behavior
- Vol. 167, 118-124
Reproductive parameters of female Wistar rats treated with methylphenidate during development
- 1 September 2015
- Published by Elsevier in Toxicology
- Vol. 335, 55-61
Evaluation of the reproductive toxicity of fungicide propiconazole in male rats
- 1 September 2015
- Published by Elsevier in Toxicology
- Vol. 335, 55-61
Evaluation of the reproductive toxicity of fungicide propiconazole in male rats
- 1 March 2015
- Published by Elsevier in Physiology & Behavior
- Vol. 140, 247-253
Effects of maternal exposure to the galactagogue Sulpiride on reproductive parameters in female rats
- 1 March 2015
- Published by Elsevier in Physiology & Behavior
- Vol. 140, 247-253
Effects of maternal exposure to the galactagogue Sulpiride on reproductive parameters in female rats
- 1 June 2014
- Published by Elsevier in Physiology & Behavior
- Vol. 133, 122-129
Effects of repeated administration of methylphenidate on reproductive parameters in male rats
- 1 June 2014
- Published by Elsevier in Physiology & Behavior
- Vol. 133, 122-129
Effects of repeated administration of methylphenidate on reproductive parameters in male rats
- 7 November 2013
- Published by SAGE Publications in International Journal of Toxicology
- Vol. 32 (6) , 426-430
Evaluation of Escitalopram, Sertraline, and Methylphenidate in the Immature Rat Uterotrophic Assay
Psychotropics are among the most prescribed medications. There are indications in the literature that fluoxetine (FLX; selective serotonin reuptake inhibitor [SSRI] antidepressant) and methylphenidate (MPH) could have a hormonal mode of action. This study was designed to evaluate the immature rat uterotrophic assay Substitute by (1) if sertraline (SER) and escitalopram (ESC) 2 other SSRI antidepressants would share the estrogenicity described for FLX and (2) MPH for estrogenicity and antiestrogenicity. The 18-day-old Wistar rats with were divided into olive oil, estradiol (0.3 mg/kg), estradiol + tamoxifen (10 mg/kg), SER (5, 15, or 45 mg/kg), ESC (2, 6, or 18 mg/kg), MPH (2.5 or 5 mg/kg), and estradiol + MPH groups. As expected, estradiol increased the weight of uterus, and this effect was counterbalanced by concomitant treatment with tamoxifen. The SER, ESC, and MPH had no effect on the uterus weight. The results suggest that ESC and SER do not share the estrogenicity described for FLX and that MPH does not disrupt estrogenic signaling.
- 7 November 2013
- Published by SAGE Publications in International Journal of Toxicology
- Vol. 32 (6) , 426-430
Evaluation of Escitalopram, Sertraline, and Methylphenidate in the Immature Rat Uterotrophic Assay
Psychotropics are among the most prescribed medications. There are indications in the literature that fluoxetine (FLX; selective serotonin reuptake inhibitor [SSRI] antidepressant) and methylphenidate (MPH) could have a hormonal mode of action. This study was designed to evaluate the immature rat uterotrophic assay Substitute by (1) if sertraline (SER) and escitalopram (ESC) 2 other SSRI antidepressants would share the estrogenicity described for FLX and (2) MPH for estrogenicity and antiestrogenicity. The 18-day-old Wistar rats with were divided into olive oil, estradiol (0.3 mg/kg), estradiol + tamoxifen (10 mg/kg), SER (5, 15, or 45 mg/kg), ESC (2, 6, or 18 mg/kg), MPH (2.5 or 5 mg/kg), and estradiol + MPH groups. As expected, estradiol increased the weight of uterus, and this effect was counterbalanced by concomitant treatment with tamoxifen. The SER, ESC, and MPH had no effect on the uterus weight. The results suggest that ESC and SER do not share the estrogenicity described for FLX and that MPH does not disrupt estrogenic signaling.